Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T1 -weighted images in pediatric patients.
Shintaro IchikawaYoshie OmiyaHiroshi OnishiUtaroh MotosugiPublished in: Journal of magnetic resonance imaging : JMRI (2018)
3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:1046-1052.